Showing results (481-490 of 757) with videos related to

Sort By:
Pageof 76
Diabetes, Obesity & Metabolism|April 1, 2020
Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA-REG OUTCOME trialSubodh Verma, Abhinav Sharma, Bernard Zinman, et al.
Orphanet Journal of Rare Diseases|May 5, 2016
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variantMalte Lenders, Frank Weidemann, Christine Kurschat, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2012
Association between pre-transplant dialysis modality and patient and graft survival after kidney transplantationAnneke Kramer, Kitty J Jager, Damian G Fogarty, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 24, 2018
Prospective cohort studies of beta-trace protein and mortality in haemodialysis patients and patients undergoing coronary angiographyDietmar Enko, Andreas Meinitzer, Hubert Scharnagl, et al.
Molecular Genetics and Metabolism|May 13, 2017
Favourable effect of early versus late start of enzyme replacement therapy on plasma globotriaosylsphingosine levels in men with classical Fabry diseaseMaarten Arends, Frits A Wijburg, Christoph Wanner, et al.
Clinical Kidney Journal|September 9, 2020
Erratum: The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY studyWilliam G Herrington, David Preiss, Richard Haynes, et al.
Clinical Transplantation|April 12, 2020
CD4+ T cell lymphopenia predicts mortality from Pneumocystis pneumonia in kidney transplant patientsTilo Freiwald, Stefan Büttner, Nardos T Cheru, et al.
Journal of Hypertension|July 4, 2020
Heart failure and renal outcomes according to baseline and achieved blood pressure in patients with type 2 diabetes: results from EMPA-REG OUTCOMEMichael Böhm, David Fitchett, Anne Pernille Ofstad, et al.
Circulation|November 4, 2024
Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-AnalysisHarpreet S Bhatia, Simon Wandel, Peter Willeit, et al.
Plos One|June 24, 2011
A distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to enzyme replacement therapyAndreas D Kistler, Justyna Siwy, Frank Breunig, et al.
Pageof 76